Evidence map›Paper›PMID 31564988›Full record

ArticleClinical, cosmetic and investigational dentistry2019

Color stability of Lucirin-photo-activated resin composite after immersion in different staining solutions: a spectrophotometric study.

Rasha AlSheikh

Open access · goldAbstract read
In one paragraph

Article in Clinical, cosmetic and investigational dentistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Rasha AlSheikhRestorative Dental Sciences Department, College of Dentistry, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.ORCID 0000-0003-2910-5511
Imam Abdulrahman Bin Faisal University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionExceptional optical properties characterize teeth. As such, an esthetic restorative material should enable the dental professional to imitate the optical properties of natural teeth accurately. IPS Empress Direct was introduced to the market with the claim that it can mimic optically dental tissues with superior clinical performance.

aimTo evaluate the ability of IPS Empress Direct to mimic tooth appearance and color and resist staining. MATERIALS AND

methodsThree disc specimens were prepared for each shade of enamel and dentin of Lucirin-based composite, IPS Empress Direct (Ivoclar Vivadent) (A1, A2, A3, B1, and B2) (total of 60). The specimens were submitted to colorimetric evaluation in comparison after immersion in 10 different solutions (coffee, coffee with sugar, coffee with milk, red tea, red tea with sugar, red tea with milk, tomato juice, pomegranate juice, coke, and distilled water as a control group) for 4 weeks using spectrophotometric analysis.

resultsAfter plotting the data and conducting linear regression analyses, IPS Empress showed high potential in mimicking the optical properties of natural tooth color according to the CIE color space. Three solutions showed a change in color higher than 3, coffee, coffee with sugar, and red tea. All other solution showed changes in color that are acceptable clinically.

conclusionIPS Empress Direct can satisfactory mimic teeth appearance and color while manifesting high stability of color resisting staining upon clinical aging.

Indexed as

composite colorcomposite shadeIPS Empressrestoration staining

Identifiers

PMID31564988
PMCPMC6733397
OpenAlexW2972038212

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.